The present invention relates to a novel peptide and a pharmaceutical composition for treating an eye disease, which comprises the same as an active pharmaceutical ingredient. When the novel peptide of the present invention is administered to the eyes, it increases the amount of tear secretion and recovers the damaged cornea. Thus, it can be advantageously used as a therapeutic agent for treating an eye disease.